Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.
University of New Mexico researchers found that the immune enzyme OTULIN drives tau production, brain inflammation and aging.
One of the most well-studied cellular responses is how they react during times of stress, such as when the temperature gets ...
The CRISPR “gene scissors” have become an important basis for genome-editing technologies in many fields, ranging from biology and medicine to agriculture and industry. A team from the Helmholtz ...
Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...
Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...
It has been claimed that because most of our DNA is active, it must be important, but now human-plant hybrid cells have been ...
In a surprising discovery, University of New Mexico researchers have found that OTULIN – an enzyme that helps regulate the immune system – also drives ...
We can replace joints, lenses, even organs—but not the brain. As neuroscience unravels the mechanisms of neurodegeneration, ...
The extreme weight loss seen in many late-stage cancer patients, known as cachexia, is far more than a cosmetic side effect.
AZoLifeSciences on MSN
CRISPR for Christmas? The year’s biggest gene editing breakthroughs, unwrapped
In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...
Clinical Trials Arena on MSN
QurAlis announces Phase I QRL-101 trial topline results in ALS
Kv7.2/7.3 channels are voltage-gated potassium channels involved in regulating membrane potential and neuronal excitability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results